Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

ConditionPostpartum Depression (PPD)

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexFemale

Age18+

SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The objectif of the IRON-DEP Study is to assess the efficacy of intravenous (IV) versus oral iron treatment on the prevalence of postpartum depression (PPD) in women with moderate iron deficiency anemia after caesarean delivery.

Eligibility criteria

Qualifiers

Age ≥18 years

Caesarean delivery (elective or in emergency)

Gestational age at delivery ≥ 32 weeks

8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL measured within 72 hours postpartum

Disqualifiers

Stillbirth or neonatal death

Last body weight available before inclusion (measured at the end of pregnancy or in postpartum) < 35kg or > 100kg

Biermer disease

Hemochromatosis

Trial design

Treatments tested in this trial

Ferric carboxymaltose IV
TIMOFÉROL®

Treatment groups

2,860 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

Source ClinicalTrials.gov